Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest lung cancers Stories

2013-10-21 13:15:33

PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23. About 3 to 5 percent of lung cancers harbor ALK gene abnormalities. The drug crizotinib (Xalkori), which blocks ALK protein kinase activity,...

2012-09-04 13:51:53

New research has revealed why some lung cancers are undetected by radiograph and helped to identify the type of people who may be at risk of this form of the disease. The findings will be presented today (Monday 3 September 2012) at the European Respiratory Society´s Annual Congress in Vienna. There has been no significant reduction in lung cancer mortality rates in recent years. Chest radiographs can be used to screen for lung cancer. However, these aren´t always effective...

2012-04-02 11:06:55

A new study led by researchers at Mount Sinai School of Medicine indicates that CT scans are more effective than traditional lung cancer detection methods at identifying aggressive lung cancers in their most treatable stages. The data, published online March 27 in the journal Radiology, demonstrate that lung cancers found through annual CT screening are similar to those found in routine practice, both in terms of tumor growth rates and cell-type distribution. In fact, the report showed that...

2012-03-30 23:02:47

A new study led by researchers at Mount Sinai School of Medicine indicates that CT scans are more effective than traditional lung cancer detection methods at identifying aggressive lung cancers in their most treatable stages. The data, published online March 27 in the journal Radiology, demonstrate that lung cancers found through annual CT screening are similar to those found in routine practice, both in terms of tumor growth rates and cell-type distribution. In fact, the report showed that...

2012-03-27 20:40:42

Growth rates of lung cancers found by annual rounds of computed tomography (CT) screening are important for determining the usefulness and frequency of screening, as well as for determining the treatment. According to the latest report from the International Early Lung Cancer Action Program (I-ELCAP) published online in the journal Radiology, lung cancers diagnosed in annual repeat rounds of CT screening are similar–both in volume doubling time and cell-type distribution– to those...

2012-01-04 06:22:32

(Ivanhoe Newswire) — Smoking is a well-known risk factor for lung cancer, but about 25% of all lung cancer patients have never smoked. According to this study, a gene fusion event could explain a significant proportion of these lung cancer cases, and may serve as a target for new therapies. Recent strides have been made to identify gene mutation events driving cases of lung adenocarcinoma in never-smokers, but the underlying genetic events leading to these lung cancers still remain...

2010-06-21 07:00:00

DAYTON, Ohio, June 21 /PRNewswire/ -- Riverain Medical® announced today that the U.S. Food and Drug Administration (FDA) has granted approval for the newest version of the OnGuard(TM) Chest X-ray Computer-Aided Detection (CAD) technology. OnGuard identifies solitary pulmonary nodules that may represent early-stage lung cancer on an existing chest X-ray (1). This improved performance demonstrates a 73% reduction in false positive marks and 50% higher relative sensitivity...

2010-04-29 13:44:17

Although more than two fifths of lung cancers are diagnosed in patients over 70, data from clinical trials on the safest and most effective treatments for this age group are scarce. Now Italian oncologists are conducting a number of trials targeting elderly patients with non-small cell lung cancer (NSCLC), and offer a review of the latest findings - and their recommendations - in the current issue of Therapeutic Advances in Medical Oncology, published by SAGE. According to Paolo Maione,...

2009-04-01 09:15:00

Georgia Institute of Technology and Saint Joseph's Hospital Team Up ATLANTA, April 1 /PRNewswire/ -- Georgia Tech and Saint Joseph's Hospital have joined together to begin the first regional research program to study the genetics and cell biology of pancreatic cancer. Tissue and serum samples from patients with cancer are being scrutinized to identify the differences in genetic and cellular features between normal and tumor cells. Findings from this research will be used for the ultimate...

2005-12-20 16:48:30

By Megan Rauscher NEW YORK (Reuters Health) - Screening chest x-ray detects a substantial number of lung cancers at an early potentially curable stage, according to initial findings from the largest US study of the efficacy of screening for lung cancer in men and women. According to the initial chest x-rays of 77,465 people in the screening arm of the trial, 5,991 -- nearly 9 percent -- had results that were deemed "suspicious for lung cancer." Upon further testing, 126 individuals...